JOANN FLOUNDERS: Open Payments
NPI 1285848853 · BROOMALL, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$572 in 31 payments from 13 companies in 2025. Trend: 2023 $1,122 · 2024 $700 · 2025 $572
Food & beverage: $572
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $215 |
| AstraZeneca Pharmaceuticals LP | 3 | $85 |
| Merck Sharp & Dohme LLC | 3 | $72 |
| Genmab U.S., Inc. | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Incyte Corporation | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Deciphera Pharmaceuticals Inc. | 1 | $19 |
Products named: IMBRUVICA, KEYTRUDA, Epkinly, VENCLEXTA, TAGRISSO, Enhertu, SCEMBLIX, LIBTAYO.
Industry payments across PA — which companies pay providers there.
